Earth Science Tech, Inc. (OTC: ETST), a strategic holding company focused on a diversified portfolio, has announced the acquisition of Zoolzy LLC, a Doral, Florida-based wholesale distributor of active pharmaceutical ingredients (APIs) and finished FDA-approved prescription products. This move is expected to significantly bolster ETST's pharmaceutical supply chain, enabling its compounding pharmacies to procure APIs at competitive wholesale pricing, which the company says could increase overall profit margins.
Zoolzy operates from a 3,684-square-foot facility and is poised to integrate seamlessly into ETST's existing operations. The acquisition not only provides cost advantages but also broadens ETST's access to novel APIs for custom compounding. This is particularly important for the company's compounding pharmacies, which rely on a diverse range of APIs to create personalized medications for patients. With Zoolzy's established distribution network, ETST can now source these ingredients more efficiently and at a lower cost, directly impacting its bottom line.
Beyond the immediate supply chain benefits, the acquisition opens new avenues for ETST in the veterinary health sector. Zoolzy provides immediate procurement access to common veterinary medications, allowing ETST to expand into the animal health market with unique, flavored, and easy-to-administer veterinary therapeutics. This initiative is being led by members of ETST's management team who have experience and established networks in the exotic wildlife space, positioning the company to capitalize on a niche but growing market.
The strategic importance of this acquisition cannot be overstated. By securing a reliable and cost-effective supply of APIs, ETST enhances its competitive edge in the compounding pharmacy industry, which is characterized by high demand for customized medications. The ability to offer competitive pricing while maintaining quality is crucial for retaining and attracting patients. Moreover, the expansion into veterinary therapeutics diversifies ETST's revenue streams, reducing its reliance on any single market segment.
This acquisition aligns with ETST's broader strategy of building a vertically integrated healthcare platform. The company aims to combine compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. By integrating Zoolzy into its supply chain, ETST strengthens its vertical integration, ensuring that the entire process from procurement to patient delivery is streamlined and efficient.
Investors and industry observers will be watching closely to see how ETST leverages this acquisition to drive growth. The company has been actively expanding its footprint in the health and wellness sector, and this move signals a clear commitment to operational excellence and market expansion. As ETST continues to execute its strategic plan, the acquisition of Zoolzy is likely to be a pivotal step in enhancing shareholder value.
For more information about Earth Science Tech, Inc., visit the company's newsroom at https://ibn.fm/ETST. To view the full press release, visit https://ibn.fm/nHFqQ.
